Author:
Scherzer Sabine,kreiner Gerhard,Stelzmüller Marie-Elisabeth,Wisser Wilfried,Neunteufl Thomas
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Grube E, Laborde JC, Gerckens U et al (2006) Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation 114:1616-1624
2. Behan M, Haworth P, Hutchinson N, et al (2008) Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv 72:1012-1015
3. Berry C, Asgar A, Lamarche Y, et al (2007) Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv 70:610-616
4. De Jaegere PP, Piazza N, Galema TW, et al (2008) Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve Revalving System aortic valve bioprosthesis. EuroIntervention 4:351-357
5. Tamburino C, Capodanno D, Mulè M, et al (2009) Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 21:93-98